Singh Harvinder 4
4 · INTEGRA LIFESCIENCES HOLDINGS CORP · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Integra Lifesciences (IART) EVP Harvinder Singh Receives RSUs; Shares Withheld
What Happened
Harvinder Singh, EVP & President, International at Integra Lifesciences (IART), reported RSU vesting and a new RSU award. On 2026-03-10 and 2026-03-11 he had RSUs convert to 20,138 shares of common stock (1,216 on 3/10 and 18,922 on 3/11). To cover tax withholding, 6,652 shares were disposed: 601 shares at $9.55 (=$5,740), 861 shares at $9.61 (=$8,274), and 5,190 shares at $9.61 (=$49,876), totaling $63,890. The filing also reports a new RSU award for 60,865 shares (reported as a derivative grant).
Key Details
- Transaction dates: vesting/conversion on 2026-03-10 and 2026-03-11; Form 4 filed 2026-03-12 (timely).
- Withholding sales/prices: 601 @ $9.55; 861 @ $9.61; 5,190 @ $9.61 — total proceeds ~ $63,890.
- Shares acquired via conversion: 20,138 (RSUs converted to common stock).
- New RSU award: 60,865 shares reported as a grant (see vesting schedule below).
- Shares owned after the transactions: not stated in the filing.
- Footnotes on vesting/tax: F1–F4 describe vesting schedules and that disposals (code F) are for tax withholding. No 10b5-1 plan or late filing indicated.
Context
- The $0.00 exercise/conversion price indicates these were restricted stock units (RSUs) vesting, not option exercises that required cash to purchase.
- The disposals were share-withholding to satisfy tax obligations (common on RSU vesting) rather than open-market sales—these are routine tax-related dispositions, not necessarily a sell signal.
- Vesting notes: F1/F2/F3 reference prior RSU grants that vested (portions on 3/10/2026 and 3/11/2026). F4 indicates the newly reported 60,865-share RSU award will vest 33%/33%/34% over the following three anniversaries beginning 3/11/2026.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-10+1,216→ 23,152 total - Tax Payment
Common Stock
2026-03-10$9.55/sh−601$5,740→ 22,551 total - Tax Payment
Common Stock
2026-03-11$9.61/sh−861$8,274→ 21,690 total - Exercise/Conversion
Common Stock
2026-03-11+18,922→ 40,612 total - Tax Payment
Common Stock
2026-03-11$9.61/sh−5,190$49,876→ 35,422 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-03-10−1,216→ 21,350 totalExercise: $0.00→ Common Stock (1,216 underlying) - Exercise/Conversion
Restricted Stock Units
[F2]2026-03-11−2,356→ 18,994 totalExercise: $0.00→ Common Stock (2,356 underlying) - Exercise/Conversion
Restricted Stock Units
[F3]2026-03-11−16,566→ 2,428 totalExercise: $0.00→ Common Stock (16,566 underlying) - Award
Restricted Stock Units
[F4]2026-03-11+60,865→ 63,293 totalExercise: $0.00→ Common Stock (60,865 underlying)
Footnotes (4)
- [F1]The award was a restricted stock unit award of which 34% vested on the third anniversary of the grant date of 3/10/2023
- [F2]The award was a restricted stock unit award of which 33% vested on the second anniversary of the grant date of 3/11/2024
- [F3]The award was a restricted stock unit award of which 100% vested on the second anniversary of the grant date of 3/11/2024
- [F4]The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026.